The FDA on Friday announced approval of zoliflodacin (Nuzolvence) as an oral treatment for gonorrhea, a day after approving oral gepotidacin (Blujepa) for the same indication. Zoliflodacin is the ...

The pathogen that causes the sexually transmitted disease gonorrhea is notorious for its ability to develop drug resistance. But now there are two more treatment options. In December, the U.S. Food ...

FARGO, N.D. (Valley News Live) -The U.S. Food and Drug Administration approved two new oral medications in December 2025 to treat uncomplicated urogenital gonorrhea, expanding options as antibiotic ...

Merck & Co. is turning down its option to license Evaxion’s gonorrhea vaccine candidate, closing the door on the Danish biotech’s chance to collect up to $592 million in biobucks. Evaxion will now ...

The Food and Drug Administration (FDA) has approved Nuzolvence ® (zoliflodacin for oral suspension) for the treatment of uncomplicated urogenital gonorrhea in adults and children aged 12 years and ...

Nuzolvence oral granules need to be mixed with water and administered within 15 minutes of mixing. The Food and Drug Administration (FDA) has approved Nuzolvence ® (zoliflodacin for oral suspension) ...

The U.S. Food and Drug Administration recently approved two new oral medicines to treat the sexually transmitted infection gonorrhea. The first approval is for Nuzolvence (zoliflodacin) granules that ...

For the first time in decades, the US Food and Drug Administration has signed off on new antibiotics to fight gonorrhea. The approvals come at a critical moment: The sexually transmitted infection is ...

What Is Nuzolvence, and Why Does It Matter? Nuzolvence (zoliflodacin) is a new oral antibiotic approved by the FDA to treat uncomplicated gonorrhea of the urinary and genital tract. It is meant for ...

Dec 12 (Reuters) - The U.S. health regulator on Friday approved Innoviva's (INVA.O), opens new tab oral antibiotic to treat gonorrhea, a common sexually transmitted infection, offering patients an ...